4Guijarro C. High sensitivity C reactive protein:potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation, 2001, 104~127.
5Curb JD, Abbott RD, Rodriguez BL, et al. C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation, 2003, 107:2016-2020.
6Albert CM, Ma J, Rifai N, et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation, 2002, 105: 2595-2599.
7Chae CU, Lee RT, Rifai N, et al. Blood pressure and inflammation in apparently healthy men. Hypertension, 2001, 38:399-403.
8Pickering TG, James GD. Ambulatory blood pressure and prognosis. J Hypertens, 1994, 12:29-33.
9Staessen JA, Asmar R, De Buyzere M, et al. Task Force Ⅱ: blood pressure measurement and cardiovascular outcome. Blood Press Monit, 2001, 6..355-370.
10Bautista LE, L6pez-Jaramillo P, Vera LM, et al. Is C reactive protein an independent risk factor for essential hypertension? J Hypertens, 2001, 19: 857-861.
